BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nevzorova YA, Boyer-diaz Z, Cubero FJ, Gracia-sancho J. Animal models for liver disease – A practical approach for translational research. Journal of Hepatology 2020;73:423-40. [DOI: 10.1016/j.jhep.2020.04.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 62] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Ashfaq I, Sheikh N, Fatima N, Tayyeb A. Inhibition of anti-inflammatory pathway through suppressors of cytokine signalling (Socs2/Socs3) in the initiation of hepatocellular carcinoma. Saudi Journal of Biological Sciences 2022;29:103348. [DOI: 10.1016/j.sjbs.2022.103348] [Reference Citation Analysis]
2 Chen J, Zhao Y, Zhang F, Li J, Boland JA, Cheng NC, Liu K, Tiffen JC, Bertolino P, Bowen DG, Krueger A, Lisowski L, Alexander IE, Vadas MA, El-Omar E, Gamble JR, McCaughan GW. Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7. Cell Mol Life Sci 2022;79:443. [PMID: 35867177 DOI: 10.1007/s00018-022-04452-6] [Reference Citation Analysis]
3 Booijink R, Salgado-Polo F, Jamieson C, Perrakis A, Bansal R. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis. EMBO Mol Med 2022;:e16333. [PMID: 35833384 DOI: 10.15252/emmm.202216333] [Reference Citation Analysis]
4 Boettger MK. What 'translating science' can learn from 'translating languages'. Drug Discov Today 2022:S1359-6446(22)00284-7. [PMID: 35787479 DOI: 10.1016/j.drudis.2022.06.013] [Reference Citation Analysis]
5 Salhab A, Amer J, Lu Y, Safadi R. Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis. Gut 2022;71:1373-85. [PMID: 34266968 DOI: 10.1136/gutjnl-2020-323345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 Malherbe DC, Messaoudi I. Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption. Front Immunol 2022;13:911951. [DOI: 10.3389/fimmu.2022.911951] [Reference Citation Analysis]
7 Huang Y, Zhang S, Weng JF, Huang D, Gu WL. Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis. Open Med (Wars) 2022;17:915-29. [PMID: 35647306 DOI: 10.1515/med-2022-0481] [Reference Citation Analysis]
8 Varani J, McClintock SD, Knibbs RN, Harber I, Zeidan D, Jawad-Makki MAH, Aslam MN. Liver Protein Expression in NASH Mice on a High-Fat Diet: Response to Multi-Mineral Intervention. Front Nutr 2022;9:859292. [PMID: 35634402 DOI: 10.3389/fnut.2022.859292] [Reference Citation Analysis]
9 Elrazik NAA, El-Mesery M, El-Shishtawy MM. Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35648193 DOI: 10.1007/s00210-022-02259-7] [Reference Citation Analysis]
10 Gama JFG, Cardoso LMDF, Lagrota-candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? WJCC 2022;10:2687-99. [DOI: 10.12998/wjcc.v10.i9.2687] [Reference Citation Analysis]
11 Gama JFG, Cardoso LMDF, Lagrota-Candido JM, Alves LA. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition? World J Clin Cases 2022; 10(9): 2685-2697 [DOI: 10.12998/wjcc.v10.i9.2685] [Reference Citation Analysis]
12 Tryndyak VP, Willett RA, Avigan MI, Sanyal AJ, Beland FA, Rusyn I, Pogribny IP. Non-Alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet. Epigenetics 2022;:1-15. [PMID: 35324388 DOI: 10.1080/15592294.2022.2043590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Köhler N, Höring M, Czepukojc B, Rose TD, Buechler C, Kröhler T, Haybaeck J, Liebisch G, Pauling JK, Kessler SM, Kiemer AK. Kupffer cells are protective in alcoholic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022. [DOI: 10.1016/j.bbadis.2022.166398] [Reference Citation Analysis]
14 Zheng G, Liu J, Yan Guo F, Zhang Z, Jiang Y, Lin Y, Lan X, Ren J, Wu Y, Nan J, Hua Jin C, Lian L. The in vitro and in vivo study of a pyrazole derivative, J-1063, as a novel anti-liver fibrosis agent: Synthesis, biological evaluation, and mechanistic analysis. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105715] [Reference Citation Analysis]
15 Martin-Grau M, Marrachelli VG, Monleon D. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn? World J Hepatol 2022; 14(2): 304-318 [DOI: 10.4254/wjh.v14.i2.304] [Reference Citation Analysis]
16 Almishri W, Swain LA, D'Mello C, Le TS, Urbanski SJ, Nguyen HH. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice. Front Immunol 2021;12:779119. [PMID: 35095853 DOI: 10.3389/fimmu.2021.779119] [Reference Citation Analysis]
17 Gupta S, Sharma A, Paneerselvan S, Kandoi S, Patra B, Bishi DK, Verma RS. Generation and transplantation of hepatocytes-like cells using human origin hepatogenic serum for acute liver injury treatment. Xenotransplantation 2022;:e12730. [PMID: 35166406 DOI: 10.1111/xen.12730] [Reference Citation Analysis]
18 Feng Z, Xiang J, Liu H, Li J, Xu X, Sun G, Zheng R, Zhang S, Liu J, Yang S, Xu Q, Wen X, Yuan H, Sun H, Dai L. Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c02002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Huang HC, Tsai MH, Chang CC, Pun CK, Huang YH, Hou MC, Lee FY, Hsu SJ. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats. Clin Sci (Lond) 2021;135:2709-28. [PMID: 34870313 DOI: 10.1042/CS20210602] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Hassan HM, Cai Q, Liang X, Xin J, Ren K, Jiang J, Shi D, Lu Y, Li T, Shang Y, He L, Chen X, Sun S, Li P, Guo B, Chen J, Yang H, Hu W, Chen X, Li J. Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats. Life Sci Alliance 2022;5:e202101189. [PMID: 34853163 DOI: 10.26508/lsa.202101189] [Reference Citation Analysis]
21 Wang J, Hu W, Shen Z, Liu T, Dai W, Shen B, Li X, Wu J, Lu L, Li S, Cai X. Dissecting the single-cell transcriptomeunderlying chronic liver injury. Mol Ther Nucleic Acids 2021;26:1364-73. [PMID: 34900395 DOI: 10.1016/j.omtn.2021.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Segovia-Zafra A, Di Zeo-Sánchez DE, López-Gómez C, Pérez-Valdés Z, García-Fuentes E, Andrade RJ, Lucena MI, Villanueva-Paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharm Sin B 2021;11:3685-726. [PMID: 35024301 DOI: 10.1016/j.apsb.2021.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kim E, Um H, Park J, Jung JW, Kim JE, Lee H, Shin EA, Pinanga Y, Lee H, Nam SH, Lee JW. TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment. Cell Rep 2021;37:110018. [PMID: 34788612 DOI: 10.1016/j.celrep.2021.110018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Abdelhamid AM, Selim A, Zaafan MA. The Hepatoprotective Effect of Piperine Against Thioacetamide-Induced Liver Fibrosis in Mice: The Involvement of miR-17 and TGF-β/Smads Pathways. Front Mol Biosci 2021;8:754098. [PMID: 34778375 DOI: 10.3389/fmolb.2021.754098] [Reference Citation Analysis]
25 Higuchi A, Wakai E, Tada T, Koiwa J, Adachi Y, Shiromizu T, Goto H, Tanaka T, Nishimura Y. Generation of a Transgenic Zebrafish Line for In Vivo Assessment of Hepatic Apoptosis. Pharmaceuticals (Basel) 2021;14:1117. [PMID: 34832899 DOI: 10.3390/ph14111117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Eslami Z, Mirghani SJ, Eghbal Moghanlou A, Norouzi A, Naseh H, Joshaghani H, Ferreira Peres WA, Younesian O, Hosseinzadeh S, Azari Bideskan J. An Efficient Model of Non-alcoholic Fatty Liver Disease (NAFLD) Versus Current Experimental Models: Effects of Fructose, Fat, and Carbon Tetrachloride on NAFLD. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.117696] [Reference Citation Analysis]
27 Im YR, Hunter H, de Gracia Hahn D, Duret A, Cheah Q, Dong J, Fairey M, Hjalmarsson C, Li A, Lim HK, McKeown L, Mitrofan CG, Rao R, Utukuri M, Rowe IA, Mann JP. A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD. Hepatology 2021;74:1884-901. [PMID: 33973269 DOI: 10.1002/hep.31897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
28 Liu JY, Cai YY, Ding ZY, Zhou ZY, Lv M, Liu H, Zheng LY, Li L, Luo YH, Xiao EH. Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging. J Magn Reson Imaging 2021. [PMID: 34545977 DOI: 10.1002/jmri.27925] [Reference Citation Analysis]
29 Chang J, Meinke J, Geck M, Hebest M, Böhling N, Dolscheid-Pommerich R, Stoffel-Wagner B, Kristiansen G, Overhaus M, Peyman LO, Klein S, Uschner FE, Brol MJ, Vilz TO, Lingohr P, Kalff JC, Jansen C, Strassburg CP, Wehner S, Trebicka J, Praktiknjo M. Extrahepatic Surgery in Cirrhosis Significantly Increases Portal Pressure in Preclinical Animal Models. Front Physiol 2021;12:720898. [PMID: 34489738 DOI: 10.3389/fphys.2021.720898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Yeh WJ, Ko J, Cheng WY, Yang HY. Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease. Br J Nutr 2021;:1-8. [PMID: 34470675 DOI: 10.1017/S0007114521003366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Israelsen M, Kim M, Suvitaival T, Madsen BS, Hansen CD, Torp N, Trost K, Thiele M, Hansen T, Legido-Quigley C, Krag A; MicrobLiver Consortium. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. JHEP Rep 2021;3:100325. [PMID: 34401690 DOI: 10.1016/j.jhepr.2021.100325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Ferrari E, Rasponi M. Liver-Heart on chip models for drug safety. APL Bioeng 2021;5:031505. [PMID: 34286172 DOI: 10.1063/5.0048986] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
33 Lu Y, Wang Q, Zhang T, Li J, Liu H, Yao D, Hou L, Tu B, Wang D. Staging Liver Fibrosis: Comparison of Native T1 Mapping, T2 Mapping, and T1ρ: An Experimental Study in Rats With Bile Duct Ligation and Carbon Tetrachloride at 11.7 T MRI. J Magn Reson Imaging 2021. [PMID: 34254388 DOI: 10.1002/jmri.27822] [Reference Citation Analysis]
34 Sato K, Zhang W, Safarikia S, Isidan A, Chen AM, Li P, Francis H, Kennedy L, Baiocchi L, Alvaro D, Glaser S, Ekser B, Alpini G. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma. Hepatology 2021;74:491-502. [PMID: 33222247 DOI: 10.1002/hep.31653] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
35 Alharshawi K, Aloman C. Murine Models of Alcohol Consumption: Imperfect but Still Potential Source of Novel Biomarkers and Therapeutic Drug Discovery for Alcoholic Liver Disease. J Cell Immunol 2021;3:177-81. [PMID: 34327512 DOI: 10.33696/immunology.3.096] [Reference Citation Analysis]
36 Ozel AB, Cilingir-Kaya OT, Sener G, Ozbeyli D, Sen A, Sacan O, Yanardag R, Yarat A. Investigation of possible neuroprotective effects of some plant extracts on brain in bile duct ligated rats. J Food Biochem 2021;:e13835. [PMID: 34173678 DOI: 10.1111/jfbc.13835] [Reference Citation Analysis]
37 Zhao H, Liu S, Zhao H, Liu Y, Xue M, Zhang H, Qiu X, Sun Z, Liang H. Protective effects of fucoidan against ethanol-induced liver injury through maintaining mitochondrial function and mitophagy balance in rats. Food Funct 2021;12:3842-54. [PMID: 33977968 DOI: 10.1039/d0fo03220d] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
38 Manicardi N, Fernández-Iglesias A, Abad-Jordà L, Royo F, Azkargorta M, Ortega-Ribera M, Sanfeliu-Redondo D, Martínez-Alcocer A, Elortza F, Hessheimer AJ, Fondevila C, Lozano JJ, García-Pagán JC, Bosch J, Cubero FJ, Albillos A, Vaquero J, Falcón-Pérez JM, Gracia-Sancho J. Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers (Basel) 2021;13:2688. [PMID: 34072510 DOI: 10.3390/cancers13112688] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
39 Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: From cell culture techniques to microfluidic organs-on-chip. Liver Int 2021;41:1744-61. [PMID: 33966344 DOI: 10.1111/liv.14942] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
40 Amato G, Saleh T, Carpino G, Gaudio E, Alvaro D, Cardinale V. Cell Therapy and Bioengineering in Experimental Liver Regenerative Medicine: In Vivo Injury Models and Grafting Strategies. Curr Transpl Rep 2021;8:76-89. [DOI: 10.1007/s40472-021-00325-2] [Reference Citation Analysis]
41 Yang A, Yan X, Fan X, Shi Y, Huang T, Li W, Chen W, Jia J, You H. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice. Hepatol Int 2021. [PMID: 34014450 DOI: 10.1007/s12072-021-10210-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
42 Groeneveld DJ, Poole LG, Luyendyk JP. Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy? J Thromb Haemost 2021;19:1390-408. [PMID: 33774926 DOI: 10.1111/jth.15312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Boyer-diaz Z, Aristu-zabalza P, Andrés-rozas M, Robert C, Ortega-ribera M, Fernández-iglesias A, Broqua P, Junien J, Wettstein G, Bosch J, Gracia-sancho J. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease. Journal of Hepatology 2021;74:1188-99. [DOI: 10.1016/j.jhep.2020.11.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
44 Liang XY, Hong FF, Yang SL. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes 2021;14:1871-83. [PMID: 33953586 DOI: 10.2147/DMSO.S304817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Bezborodkina NN, Okovityi SV, Kudryavtsev BN. Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver. Cells 2021;10:976. [PMID: 33919385 DOI: 10.3390/cells10050976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Ramot Y, Deshpande A, Morello V, Michieli P, Shlomov T, Nyska A. Microscope-Based Automated Quantification of Liver Fibrosis in Mice Using a Deep Learning Algorithm. Toxicol Pathol 2021;49:1126-33. [PMID: 33769147 DOI: 10.1177/01926233211003866] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
47 Maeso-Díaz R, Gracia-Sancho J. Aging and Chronic Liver Disease. Semin Liver Dis 2020;40:373-84. [PMID: 33764489 DOI: 10.1055/s-0040-1715446] [Reference Citation Analysis]
48 Kruchinin AG, Savinova OS, Glazunova OA, Moiseenko KV, Agarkova EY, Fedorova TV. Hypotensive and Hepatoprotective Properties of the Polysaccharide-Stabilized Foaming Composition Containing Hydrolysate of Whey Proteins. Nutrients 2021;13:1031. [PMID: 33806781 DOI: 10.3390/nu13031031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Benedé-Ubieto R, Estévez-Vázquez O, Guo F, Chen C, Singh Y, Nakaya HI, Gómez Del Moral M, Lamas-Paz A, Morán L, López-Alcántara N, Reissing J, Bruns T, Avila MA, Santamaría E, Mazariegos MS, Woitok MM, Haas U, Zheng K, Juárez I, Martín-Villa JM, Asensio I, Vaquero J, Peligros MI, Argemi J, Bataller R, Ampuero J, Romero Gómez M, Trautwein C, Liedtke C, Bañares R, Cubero FJ, Nevzorova YA. An Experimental DUAL Model of Advanced Liver Damage. Hepatol Commun 2021;5:1051-68. [PMID: 34141989 DOI: 10.1002/hep4.1698] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Zhang Y, Bi M, Chen Z, Dai M, Zhou G, Hu Y, Yang H, Guan W. Hydrogen gas alleviates acute alcohol-induced liver injury by inhibiting JNK activation. Exp Ther Med 2021;21:453. [PMID: 33767761 DOI: 10.3892/etm.2021.9884] [Reference Citation Analysis]
51 Gracia-sancho J, Caparrós E, Fernández-iglesias A, Francés R. Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol 2021;18:411-31. [DOI: 10.1038/s41575-020-00411-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 30.0] [Reference Citation Analysis]
52 Su X, Chen D, Li L, Li L. High-coverage quantitative liver metabolomics using perfused and non-perfused liver tissues. Anal Chim Acta 2021;1153:338300. [PMID: 33714446 DOI: 10.1016/j.aca.2021.338300] [Reference Citation Analysis]
53 Selicean S, Wang C, Guixé-Muntet S, Stefanescu H, Kawada N, Gracia-Sancho J. Regression of portal hypertension: underlying mechanisms and therapeutic strategies. Hepatol Int 2021;15:36-50. [PMID: 33544313 DOI: 10.1007/s12072-021-10135-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Gupta H, Suk KT, Kim DJ. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. J Clin Med 2021;10:541. [PMID: 33540624 DOI: 10.3390/jcm10030541] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
55 Soret PA, Magusto J, Housset C, Gautheron J. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. J Clin Med 2020;10:E36. [PMID: 33374435 DOI: 10.3390/jcm10010036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kořínková L, Pražienková V, Černá L, Karnošová A, Železná B, Kuneš J, Maletínská L. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. Front Endocrinol (Lausanne) 2020;11:597583. [PMID: 33324348 DOI: 10.3389/fendo.2020.597583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
57 Alharshawi K, Fey H, Vogle A, Klenk T, Kim M, Aloman C. Sex specific effect of alcohol on hepatic plasmacytoid dendritic cells. Int Immunopharmacol 2021;90:107166. [PMID: 33199233 DOI: 10.1016/j.intimp.2020.107166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Lin SZ, Chen YW, Fan JG. Non‐alcoholic fatty liver disease to metabolic dysfunction‐associated fatty liver disease : Conceptual changes for clinicians, researchers and patients. J Dig Dis 2020;21:604-9. [DOI: 10.1111/1751-2980.12944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
59 Guixé-muntet S, Zhu C, Xie W, Gracia-sancho J. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease. Pharmacology & Therapeutics 2020;215:107626. [DOI: 10.1016/j.pharmthera.2020.107626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
60 Morikawa R, Nakamoto N, Amiya T, Chu PS, Koda Y, Teratani T, Suzuki T, Kurebayashi Y, Ueno A, Taniki N, Miyamoto K, Yamaguchi A, Shiba S, Katayama T, Yoshida K, Takada Y, Ishihara R, Ebinuma H, Sakamoto M, Kanai T. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. J Hepatol 2021;74:511-21. [PMID: 33038434 DOI: 10.1016/j.jhep.2020.09.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
61 Aravalli RN, Steer CJ. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes (Basel) 2020;11:E729. [PMID: 32630053 DOI: 10.3390/genes11070729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
62 Caparrós E, Juanola O, Gómez-Hurtado I, Puig-Kroger A, Piñero P, Zapater P, Linares R, Tarín F, Martínez-López S, Gracia-Sancho J, González-Navajas JM, Francés R. Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis. Cells 2020;9:E1227. [PMID: 32429209 DOI: 10.3390/cells9051227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]